Here's Won't Touch Teva: Why I Pass on the Generic Giant
Teva Pharmaceuticals sits at a crossroads of debt, generics, and a shifting pricing landscape. Here's why I won't tou...
Learn effective ways to earn money in a month for debt relief. Take action now to improve your financial situation.
18,616 articlesTeva Pharmaceuticals sits at a crossroads of debt, generics, and a shifting pricing landscape. Here's why I won't tou...
A sizzling 12.7% ultra-high-yield dividend can boost income, but safety matters. This guide shows how to screen, vali...
Markets watch the debt path as deficits and entitlement costs rise. A budget watchdog warns that the current calm cou...
The U.S. sits on a $38 trillion debt path that investors and households will feel long before any sudden crunch. Poli...
Investors are watching Summit Midstream (SMC) 2026 Q1 earnings for clues on cash flow, debt, and future distributions...
Pfizer’s high dividend yield is eye-catching, but a big payout can hide hidden risks. This article explains the warni...
America’s debt has surged to WWII-era levels even as growth accelerates. Here’s what the numbers show and why investo...
Too many savers don’t know what they’re paying in retirement plan fees. This guide shows you how to uncover those cos...
Old homes are cash machines for savvy flippers, but growing bureaucratic delays complicate rehab plans. Learn where r...
Two separate California cases show how funds meant for students can be diverted into luxury purchases. This article e...
Managed futures ETFs offer a path to diversification when risks rise across markets. This guide explains how they wor...
Counterfeit money can slip into everyday transactions and end up funding gift cards via fraud. This guide explains th...